died 10 years after onset.
This disease exists mostly as an independent condition.
However, from the fact that it is also observed as a complication in patients with partial lipodystrophy, a congenital disease, at a high incidence, it is considered to be related to a congenital abnormality.
In this disease, low complement titer is observed, the same as in acute glomerulonephritis, and C3NeF, an antibody specific to C3bBb, is demonstrated in somecases.
(2) Changes in the complement system in primary glomerular disease only at the onset. In this case, the low complement takes an alternative pathway, in which the complement components of more than C3 decrease. In membranoproliferative glomerulonephritis, the complement is generally low although it varies greatly. The low complement takes an alternative or classical pathway, or both.
In lupus nephritis, the complement is continuously low unless the symptoms are otherwise improved. The low complement almost always takes a classical pathway in which the complement componentsof more than Clq decrease.
In the morbid types other than these abovementioned three types, there are very few cases showing low complement titer.
Instead, most
show normal or high complement titer.
(b) Deposition of complements in the glomeruli In these diseases in which such characteristic serum complement activity is shown, except for IgA nephropathy, deposition of complements in the glomeruli is observed in the same way as in changes in the serum complement activity.
In the case of acute proliferative glomerulonephritis, the early components such as Cl, C4, etc. are faintly stained and components of more than C3 are the ones that are stained (Fig. 1) (d) The relationship between C3NeF and membranoproliferative glomerulonephritis
In some cases of membranoproliferative glomerulonephritis, the complement titer continues to be extremely low. The low complement titer is believed to be due to C3NeFin most cases.
The author studied the characteristics of C3NeF in blood.
C3NeF is a kind of IgG and an autoantibody to C3bBb.6"8) C3NeF, which is resistant to heat, is converted into CcbBb-C3NeF and is retained in the living body without being further dissolved. CAPD is a method in which dialysis is performed continuously.
An indwelling catheter is inserted into the peritoneum and the dialysis fluid is continuously injected into a plastic bag outside the body.
By means of such peritoneal dialysis, CAPD is able to exhibit an excellent effect in removing substances with middle-sized molecules, such as guanidino compounds.
The largest number of dropouts from CAPD are due to peritonitis.
There are also some dropouts due to occlusion of the catheter or complications of myocardial infarction. Some cases of renal failure associated with diabetic nephropathy drop out from CAPDdue to lactic acidosis. In the near future, CAPDis expected to be more widely applied clinically based on studies of the composition of the dialysis fluid. Despite the fact that the morbidity has not changed, the mortality has been decreasing markedly. This trend is due to the development of modern nephrology.
In particular, countermeasures for renal failure have been rapidly developing, resulting in the marked decrease in mortality. It is also hoped that the therapeutic effect will be improved in this field.
